Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia corporate presentation – SFAF Event from adocia

Latest Press Releases

2019/03/13Adocia Announces its Financial Results for 2018: Higher Revenue and Reinforced Cash Position
2019/03/08Number of shares and voting rights of ADOCIA as of February 28, 2019

All Press releases

Next events

March 25-27, 2019 BioEurope Spring, Vienna, Austria - Europe’s largest springtime biotech partnering event.

All events

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.

Financial

Welcome to the investors section of Adocia

Adocia presents an oral presentation and two “Posters” at the Annual Congress of the Francophone Diabetes Society in Marseille

ATTD 2019: Abstracts details